Leptin Levels in Papillary Thyroid Cancer (LL-PTC)
The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.
Thyroid Cancer, Papillary
|Study Design:||Time Perspective: Cross-Sectional|
|Official Title:||Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls|
- evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid. [ Time Frame: During Study ] [ Designated as safety issue: No ]Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.
|Study Start Date:||August 2012|
|Estimated Study Completion Date:||June 2013|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01659385
|United States, Nebraska|
|University of Nebraska Medical Center|
|Omaha, Nebraska, United States, 68198|
|Principal Investigator:||Whitney Goldner, MD||University of Nebraska|